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ABSTRACT
Considering the widespread popular use of Morus nigra and the amount of scientific 
information on its antioxidant and anti-inflammatory activity, the effectiveness of this 
phytotherapeutic compound in the parasitemia progression during the acute phase of Chagas 
disease and its role in the development of the inflammatory process as well as its effects 
on the oxidative damage in the chronic phase of infection were evaluated. Thus, 96 male 
Swiss mice were randomly divided into eight groups, four groups were uninfected controls, 
and four groups were intraperitoneally infected with 5.0 x 104 blood trypomastigotes forms 
of T. cruzi QM2 strain. Four batches composed of one uninfected and one infected group 
were respectively treated with 70% alcohol solution and 25 μL, 50 μL and 75 μL of the 
phytotherapeutic compound. Levels of antioxidant elements (TBARS, FRAP, GSH and 
Sulfhydryl groups) were measured in plasma samples. The phytotherapeutic compound’s 
antioxidant activity was measured by polyphenol and total flavonoid quantification, DPPH, 
NO, and FRAP method. Our results showed that the vehicle influenced some of the results that 
may have physiological relevance in Chagas disease. However, an important action of M. nigra 
tincture was observed in the progression of Chagas disease, since our results demonstrated 
a reduction in parasitemia of treated groups when compared to controls, especially in the 
group receiving 25 μL. However, in the chronic phase, the 50-μL dosage presented a better 
activity on some antioxidant defenses and minimized the tissue inflammatory process. Results 
indicated an important action of M. nigra tincture on the Chagas disease progression.
KEYWORDS: Phytotherapy. Herbal medicine. Herbal compounds. Phytotherapeutic 
compound. Plant extracts. Parasitic diseases. Blackberry. Oxidative stress.
INTRODUCTION
Chagas disease is a parasitic and inflammatory infection caused by the protozoan 
Trypanosoma cruzi (T. cruzi) discovered in 1909. It is estimated that, from 2000 to 
2011, more than 1,200 cases were recorded, 70% of infections were acquired by oral 
transmission, 7% by vectorial transmission and 22% did not have the transmission 
mode identified1.
The vectorial transmission occurs with penetration of metacyclic trypomastigote 
forms in the host leading to the development of the disease’s acute phase. This initial 
phase can last from thirty to ninety days, with presence of high levels of parasites 
in bloodstream (parasitemia) and tissue, which may go unnoticed in most infected 
individuals due to insufficient clinical signs and symptoms2. Subsequently, the 
chronic phase of disease may be asymptomatic or symptomatic when cardiac and 
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digestive clinical manifestations are observed. Symptomatic 
chronic phase of Chagas disease is characterized by low 
parasitemia and high level of antibodies, which makes the 
laboratory diagnosis possible through several different 
techniques3,4. 
During the life cycle of T. cruzi, free radicals resulting 
from oxidative stress caused by both host immune response 
and parasite’s aerobic metabolism and, occasionally, by 
drugs used to treat the disease, are associated with the 
appearance of tissue damage5.
In this sense, the excessive production of free radicals 
can trigger oxidative stress and, consequently, the loss of 
primordial cellular functions, which can lead to apoptosis 
and / or cell necrosis6. Studies have shown that increased 
oxidative stress is associated with disease progression 
and the use of antioxidant elements has been effective in 
attenuating the oxidative damage caused by disease and 
may influence its course7,8. 
In this context, several studies have demonstrated 
the efficacy of different phytotherapeutic compounds as 
effective antioxidant agents against many diseases, such as 
Alzheimer’s, thyroid disorders, hypertension and obesity9-11. 
Morus nigra (M. nigra), popularly known as mulberry 
or blackberry, stands out for its edible fruits with bittersweet 
flavor and also for the wide popular use of its leaves as 
an hypoglycemic agent in the complementary treatment 
of diabetes mellitus and in menopause by attenuating 
climacteric symptoms12. Other studies have also highlighted 
its use as an analgesic, anti-inflammatory, antipyretic, 
antiseptic, healing, depurative and diuretic, anthelmintic 
and emetic13-15. Several chemical compounds such as 
alkaloids, coumarins, flavonoids, triterpenes and steroids 
have been investigated in the Morus genus and researches 
have been carried out to prove these compounds’ action on 
specific receptors, especially polyphenolic ones present in 
leaves and fruits of M. nigra, due to the presence of a wide 
spectrum of biochemical activities, such as antioxidant, 
antimicrobial, antimutagenic and immunoregulatory 
properties16,17.
Although the role of free radicals in inflammatory 
processes is widely discussed, their interactions in the 
body deserve extensive investigations18. In this context, the 
activity of M. nigra in the parasitemia progression during 
the acute phase of Chagas disease, as well the influence 
of this phytotherapeutic compound in the development of 
the inflammatory process in the chronic phase of infection 
and its effects on the oxidative damage originated from 
infection in a murine model were evaluated, considering 
its widespread popular use and the amount of scientific 
information on its antioxidant, anti-inflammatory and anti-
aging activities.
MATERIALS AND METHODS
Phytotherapy compound’s antioxidant activity
The phytotherapy compound used in this research was 
a 20% M. nigra (blackberry) leaf dye purchased from 
the Panizza laboratory (batch Nº 16013B124, reference 
MAP012), produced in May/2012 with expiration date in 
May/2016. 
This phytotherapy compound was diluted in different 
concentrations, which were later used in in vitro antioxidant 
activity tests, as well as in the characterization of 
polyphenols and flavonoids. As for the animal’s treatment, 
the phytotherapy compound was administered in different 
dosages according to the distribution of study groups. The 
Ethics Committee on the Use of Animals of the Medical 
School of Marília/CEUA-FAMEMA has approved the 
experimental study under the protocol Nº 178/14. 
Antioxidant activity test (DPPH)
The phytotherapy compound’s antioxidant activity 
was determined by the H + donor ability to the stable 
radical 1,1-diphenyl-2-picrylhydrazyl, according to the in 
vitro methodology proposed by Blois19. The phytotherapy 
compound reacted with DPPH radical for a period of thirty 
minutes under low light and then subjected to a UV-vis 
Femto® spectrophotometer at a 517-nm wavelength. The 
antioxidant activity of the phytotherapy compound can be 
seen by the reagent’s degree of discoloration required for 
the reaction to attain a plateau, and also by the low IC50 
value translating the phytotherapy compound’s ability to 
inhibit radical oxidation by 50%. Gallic acid was used as 
the standard.
Ferric Reducing the Antioxidant Power (FRAP)
The FRAP assay was performed as previously described 
by Benzie and Strain20. Sample or Trolox standard was 
mixed with distilled water to prepare the FRAP reagent 
extemporaneously, which was subsequently incubated at 
37 ºC for 30 min. Maximum absorbance values were read 
at 595 nm UV-vis Femto® spectrophotometer. Results were 
expressed as micromoles of Trolox Equivalents (TE) per 
mL of extract.
Antioxidant ability assessment through the nitric oxide 
(NO) scavenging assay
The method used to measure this phytotherapy 
compound’s antioxidant ability was based on the Griess 
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et al.21 methodology with adaptations. The experiment 
was performed by transferring a 320-μL aliquot of each 
extract into test tubes, adding 360 μL of 25 mM NPS 
solution and 215 μL of Griess reagent. They were kept in 
a water bath for 150 min at 37 ºC and were then allowed 
to stand for an additional 60 min at room temperature. For 
the preparation of the standard curve, solutions ranging 
in concentrations from 5 to 60 μM/mL were prepared 
from the standard sodium nitrite solution of 500 μM/mL. 
Absorbance readings were performed using UV-vis 
Femto® spectrophotometer at 540 nm and the mean and 
nitrite concentration in μM/mL were calculated from the 
absorbances obtained.
Total phenol content
The Folin-Ciocalteu method was used to determine 
the total phenol content in the extracts, with gallic acid 
as the comparative standard22. Phytotherapy compound’s 
samples at different concentrations, distilled water 
and the Folin-Ciocalteu reagent were added. Then, the 
absorbance was measured at 725 nm using a UV-vis Femto® 
spectrophotometer. All measurements were performed in 
triplicate and results were expressed in μg of gallic acid/
mL of the phytotherapy compound. 
Flavonoid content
The total flavonoid content of the phytotherapy 
compound was determined by a UV-vis spectrophotometer, 
and samples were prepared according to the methodology 
proposed by Yao et al.23, based on the flavonoid complexation 
with AlCl3, which dislocates the absorption bands to higher 
wavelengths. Samples were shaken in a vortex shaker and 
the absorbance was measured at 510 nm using UV-vis 
Femto® spectrophotometer. All the tests were performed in 
triplicate and the results were expressed in μg of rutin/mL 
of the phytotherapy compound. 
Animal setting and infection methodology 
A total of 96 male Swiss mice with 20 days old 
were randomly divided into eight groups of 12 animals, 
consisting of 4 (-) groups of uninfected animals and 4 (+) 
groups of infected animals. The infected groups (+) received 
5.0 x 104 blood trypomastigotes forms of T. cruzi QM2 
strain intraperitoneally, characterized by Martins et al.24, 
from another infected mouse. One (C (+)) and one (C (-)) 
groups were used as controls and received 50 μl of 70% 
alcohol solution because this solution was the basis of the 
M. nigra phytotherapy compound. 
The other 6 groups were treated with the phytotherapy 
compound and received 25 μL, 50 μL and 75 μL, these 
groups were named 25(+), 25(-), 50(+), 50(-), 75(+) and 
75(-). All treatments were carried out every day in the 
morning and the mice received the alcohol solution or the 
phytotherapy compound orally (in their mouth) through 
a Gilson® automatic pipette tip for a period of 180 days. 
Treatment, care and euthanasia of the mice followed CEUA/
FAMEMA standards (protocol: 178/14). 
Parasitemia analysis
Parasitemia was investigated during the acute phase 
of infection (60 days), according to Brener’s method25. 
Twice a week we collected 5 μl of blood from the tails 
of five animals from each infected group, starting on the 
7th day after infection, totaling 17 counts to each animal. 
These animals were randomly chosen and kept in isolated 
cages until the end of the experiments and treatment was 
administered normally until the end of the chronic phase.
Euthanasia, samples collection and preparation
For the histopathological and biochemical study, animals 
were euthanized with 100% CO2 on the 180th day after 
infection. The blood sample of each mouse was collected 
by cardiac puncture in tubes containing heparin, and the 
hemolysate was immediately performed to determine 
glutathione reduction according to the methodology used. 
The remainder of the blood sample was centrifuged at 
1,110 g for 5 min at 4 ºC and the collected plasma was 
stored at -20 °C for use in other biochemical tests.
Histopathological study
For histopathological analysis, fragments of heart, colon 
and skeletal muscle tissue were collected from all mice that 
survived until the 180th post-infection day. The tissues were 
embedded in paraffin and 5 μm sections, were stained with 
hematoxylin-eosin and examined under a light microscope 
with 400x magnification. For each fragment, five sequential 
histological sections were performed, which were analyzed 
and graded according to the intensity of the inflammation 
process and the amount of amastigotes nests. A total of 10 
high magnification fields were analyzed for each type of 
tissue. A semiquantitative scale varying from zero to three 
was used to grade the inflammatory process, the amastigote 
nests and the necrosis. “Zero” was considered as the absence 
of inflammation, necrosis and amastigote nests, “+” - mild 
inflammation, and rare amastigote nests and necrosis, “++” 
- moderate inflammation, moderate number of amastigote 
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nests and necrosis, and “+++” - intense inflammation, 
frequent amastigote nests and necrosis.
Antioxidant activity and oxidative stress assessment 
in vitro 
FRAP
The antioxidant ability was determined using the 
technique described by Benzie and Strain20. It is based on 
the ability of the plasma to reduce the FeIII to FeII ions in the 
presence of 2,4,6-tripyridyltriazine at low pH, which results 
in the formation of a blue color read in a spectrophotometer 
at 593 nm. Plasma antioxidant ability was determined 
for each sample by comparing the absorbance test with 
the absorbance of FeII solutions of known concentrations 
(100-1000 mmol/L) tested in parallel.
TBARS
The thiobarbituric acid reactive species (TBARS), 
used as biomarkers of lipid peroxidation, was measured 
in plasma using a method adopted from Yagi26. TBARS 
samples concentrations were determined by comparing 
their absorbance with a standard malondialdehyde solution.
GSH
This method relies on the reduction of 5,5’-dithiobis 
acid (2-nitrobenzoic acid) (DTNB). The concentration 
of erythrocyte glutathione (GSH) was determined by the 
colorimetric method developed by Beutler27. The DTNB in 
the presence of glutathione produces a yellow compound, 
the optical density of which is measured at 412 nm. The 
concentration of GSH was expressed in mmol/g of Hb.
Total sulfhydryl groups (Ellman’s test protocol)
The methodology proposed by Sedlak and Lindsay28 
using the Ellman reagent DTNB (5,5´-dithio-bis 
2-nitrobenzoic acid) was employed. The thiol groups of the 
sample react with DTNB, forming a complex that absorbs 
light at 412 nm. The concentration of the total sulfhydryl 
groups was calculated by the equation {[(Absorbance2 - 
Absorbance1] - White)/ Ɛ* DTNB} x dilution x 1000 with 
the molar absorption coefficient used for DTNB Ɛ =13,600 
cm-1 M-1.
Statistical Analysis
Data normality was verified using the Shapiro-Wilk test 
(W). The ANOVA test was used for the comparisons between 
three or more groups complemented by the Tukey test. The 
Games-Howell test was used when the homogeneity of the 
variances was unidentified. Kruskal-Wallis non-parametric 
analysis of variance (KW), complemented by Dunn’s test for 
multiple comparisons, was used when data normality was not 
identified in at least one of the groups in comparison29. The 
level of significance was set at 5%.
RESULTS
Phytotherapy compound’s antioxidant activity: 
polyphenol and total flavonoid quantification, DPPH, 
NO and FRAP method
The assessment of the phytotherapy compound’s 
polyphenol and total flavonoid concentrations showed 
261.66 μg of gallic acid equivalent/mL and 361.83 μg of 
equivalent routine/mL of the phytotherapy compound, 
respectively.
To determine the antioxidant activity by the FRAP 
method, 32.09 μM of trolox/g equivalent of the phytotherapy 
compound was used. Similarly to the DPPH test, Figure 1 
shows that once different dilutions and pure phytotherapy 
compound were used, the antioxidant activity was 
progressively increased with increasing concentrations 
and the highest antioxidant activity was observed at 
250 μL/mL of concentration presenting 81% of reduction, as 
shown in Table 1, and EC50= 72.28 μL/mL (Figure 1).The 
potential for NO sequestration has also been tested. For this 
assessment, it was possible to verify a concentration of 13.64 
μM/mL of nitrite formed, values close to those obtained with 
the gallic acid control that presented 10.11 μM/mL. 
Assessment of parasitemia in the acute phase
It is possible to observe that, in Figure 2, since the first 
count, the group C(+) presented with higher parasitemia 
when compared to the groups treated with the phytotherapy 
Figure 1 - Free radical scavenging activity DPPH in M. nigra - 
phytotherapy compound
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compound, remaining superior throughout the analyzed 
period.
It was observed that the different concentrations were 
statistically different when compared to control groups, 
which exhibited the highest levels of parasitemia. It 
was verified that the 25(+) group exhibited the lowest 
parasitemia with p <0.05, when compared to 50(+), 75(+) 
and C(+). The groups that received 50(+) and 75(+) showed 
p <0.05 when compared to the C(+)
Assessment of antioxidant ability in plasma
The antioxidant capacity of the phytotherapy compound 
was performed in the animals that survived the studied 
period, as can be observed in Table 2.
FRAP
Taking into account the absence of infection, it is 
possible to observe that in Figure 3 the phytotherapy 
compound administration increased the concentrations 
of FRAP at the doses of 50(-) and 75 (-) in a similar way 
(p=0.05), but these results differed from the one obtained 
for 25(-) (p<0.05). These values did not differ statistically 
from group C(-).
When comparing FRAP concentrations in the different 
dosages with C(-), although increments can be observed, 
these differences did not reach statistical significance (p> 
0.05). This may suggest an effect of the alcoholic vehicle 
acting in a dose dependent manner, with a maximum effect 
in the 50(-) group.
To evaluate the animals, compared with the C (+) group, 
Table 1 - Free radical DPPH and nitric oxide (NO) scavenging activity, polyphenols, total flavonoid and FRAP test in M. nigra - 
phytotherapy compound
Total Polyphenolsa Total Flavonoidsb FRAPc DPPH 
EC50% (µl/mL)
Nitric Oxided 
Control: 10.11e
Phytomedicine 261.66 361.83 32.09 72.2 13.64
aµg of gallic acid quivalent/mL of the phytomedicine, bµg of rutine equivalent/mL of phytomedicine. cµM trolox equivalent/g of phyto-
medicine. dµM/mL of nitrite concentration formed by the antioxidant capacity of NO capture. e µM/mL of gallic acid.
Figure 2 - Parasitemia curve by logarithmic mean of the number of trypomastigotes/5 µL of blood in the different experimental 
groups during the acute phase from the 7th to the 60th day of infection
Table 2 - Number of animals that survived in each group during 
the chronic phase of infection 
Group Number of animals
Uninfected Control(-) 11
25µL(-) 11
50µL(-) 11
75µL(-) 9
Infected Control(+) 8
25µL(+) 10
50µL(+) 8
75µL(+) 12
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only the group 75 (+) showed a statistically significant 
difference (p <0.05) with increasing FRAP concentrations. 
When the effect of different dosages of each uninfected 
group was compared with its infected counterpart, 
differences (p<0-.05) were observed in the group that 
ingested 50 μL, which, when under infection, had their 
FRAP values decreased.
When comparing the controls with their infected 
counterparts, the 50 μL group showed a greater reduction 
of approximately 30% when under infection condition 
(p<0.05). The effects of the different dosages of each 
uninfected group were compared with –the infected 
counterparts and significant differences (p<0-.05) were 
observed in the group that ingested 50 μL, which, when 
under infection, had their FRAP values decreased in 
approximately 30% (p<0.05). .
TBARS
It was observed that, in Figure 4, the C(-) group 
produced TBARS levels which were relatively higher than 
those obtained in the other groups with or without infection, 
not differing only from the 25(-) group, and this dosage 
showed the highest level of peroxidation in the absence 
of infection.
However, in relation to the 50(-) and 75(-) groups, 
when compared to C(-), there was a statistically significant 
reduction in TBARS levels of approximately 80%. This may 
indicate that the presence of the phytotherapy compound 
at these concentrations minimizes the possible alcohol-
induced lipid peroxidation.
The C(+) group did not differ statistically from the other 
infected groups. The animals of 75(+) presented higher 
levels of TBARS when compared to C(+), but without 
statistical significance. Between the 25(+) and 50(+) groups, 
there were also no statistically significant differences.
GSH
Regarding GSH concentrations, as seen in Figure 5, 
the group’s 25(-), 50(-) and 75(-) presented higher 
concentrations of GSH when compared to C(-) group 
receiving the alcoholic solution, indicating that the 
phytotherapy compound induced effects mainly among 
animals receiving 50 μL and 75 μL of tincture.
When comparing C(+) and C(-), there was no 
statistically significant difference, evidencing that, in the 
chronic phase, the infection is not acting as an inducer of 
GSH synthesis.
Figure 3 - FRAP results in different concentrations of the 
phytotherapy compound of M. nigra expressed in mean and 
standard deviation. Averages followed by the same designation 
do not differ from one another by the Dunn test at the 5% 
probability level
Figure 4 - TBARS results in different concentrations of the 
phytotherapy compound of M. nigra expressed in mean and 
standard deviation. Averages followed by the same designation 
do not differ from one another by the Dunn test at the 5% 
probability level
Figure 5 - GSH results in different concentrations of the 
phytotherapy compound of M. nigra expressed in mean and 
standard deviation. Averages followed by the same designation 
do not differ from one another by the Dunn test at the 5% 
probability level
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It is also possible to observe that, among the infected 
groups, differences were not statistically significant among 
them, nor when they were compared to C(+), suggesting that 
the phytotherapy compound does not increase glutathione 
in the chronic phase infection.
However, for the groups that received 50 μL and 75 μL, 
the values are relevant when compared to the respective 
uninfected groups, because there is a statistically significant 
decrease, suggesting that the glutathione decrement is 
inherent to the its consumption during the infection process. 
When comparing 50(-) and 75(-) with each other, they were 
not statistically different, inferring a maximal inducing 
effect at 50 μL. 
Total Sulfhydryl Groups
Figure 6 shows that the 25(-) dosage decreased the 
total sulfhydryl groups in relation to 50(-) (p<0.05). This 
dosage, however, was not different from the concentration 
observed in 75(-), differing, however, from C(-) (p<0.05). 
This may evidence a possible phytotherapeutic effect 
at this concentration in increasing this type of defense 
mechanism.
Among the animals in the infected groups, no 
statistically significant difference was observed, a fact 
that has also occurred when they were compared to C(+) 
(p=0.05). When comparing the uninfected groups with their 
respective infected counterparts, the differences were also 
not statistically significant.
Histopathological study
Considering uninfected animals that received tincture, 
no inflammation, necrosis or amastigote nests were observed 
in the histopathological analysis. Table 3 demonstrates 
exclusively the animals that presented any change in one 
or more of the analyzed parameters.
It was observed that the highest levels of inflammation 
were found in the skeletal muscle, heart and colon 
(Figure 7A), respectively, in all study groups.
In skeletal muscle, all animals in the 25 (+) group 
presented inflammatory process, being 90% discrete ad 
10% moderate; however, 37.5% of the animals in group 
C (+) presented moderate inflammation. Regarding the 
heart, although C (+) presented a greater number of animals 
(87.5%) with mild inflammatory process in the heart, in 
the group 25 (+) 40% of the animals presented moderate 
inflammation. As for the colon, the group C (+) had a higher 
number of animals with inflammatory process.
However, as shown in Figure 7B, the 25 (+) group had 
a higher number of animals with amastigote nests. In the 
case of necrosis, all groups had necrotic processes in skeletal 
tissues in 2 animals from each group, as shown in Figure 7C.
DISCUSSION
Several studies have demonstrated the relationship 
between oxidative stress and antioxidant defenses during 
the course of infection and progression of Chagas disease 
in humans and experimental models7,30. 
The intense pharmacological potential of phenolic 
compounds and the presence of flavonoids can result in the 
ability to act on inflammation and on the immune system31. 
In addition, the antioxidant activity of these compounds is 
predominantly due to their ability to act as reducing agents 
of reactive oxygen species (ROS), in addition of reducing 
or chelating ferric ions that catalyze lipid peroxidation32.
Thus, the in vitro results obtained in this research 
(Table 1) corroborated several studies demonstrating 
that M. nigra leaves constitute a rich source of phenolic 
compounds capable of positively impacting human health, 
in addition to presenting a higher content of phenolic 
compounds and antioxidant activity when compared to 
its fruits33,34.
Our results showed that the 25 (+) group exhibited 
a lower parasitemia when compared to the other groups 
(Figure 2). This decrease could be related to the anti-
inflammatory activity of M. nigra leaves that contain 
germanicol among other compounds, which is described as 
an important natural anti-inflammatory, since flavonoids act 
modulating cells involved with inflammation16.
In addition, this decrease may be related to the 
availability of NO, since the ability to inhibit NO synthesis 
Figure 6 - Sulfhydryl groups results in different concentrations 
of the phytotherapy compound of M. nigra expressed in mean 
and standard deviation. Averages followed by the same 
designation do not differ from one another by the Dunn test at 
the 5% probability level
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by leaf extracts of the Morus genus is described in a dose-
dependent manner35. Thus, results could indicate that the 
lower dose of tincture used in the treatment induced a 
greater control of parasitemia (Figure 2) by allowing a 
greater availability of nitric oxide, which plays an important 
role in the defense system to combat the parasite.
However, animals from the C (+) group showed patent 
parasitemia for a longer period of time probably due to 
Table 3 - Histopathological analysis performed in skeletal muscle, cardiac muscle and colon during the chronic phase of infection, 
in mice experimentally infected by Trypanosoma cruzi QM2 strain and treated with alcoholic solution (control), 25, 50 and 75 µL 
of Morus nigra phytotherapy compound.”%” indicates the percentage of mice with inflammation or necrosis in each group, and ( ) 
* indicates the absolute number of animals in each group 
Groups Histological Analysis Skeletal muscle Cardiac muscle Colon
C(+)
Inflammation 
%(8)*
+ 50.0 (4) 87.5 (7) 62.5 (5)
++ 37.5 (3) --- ---
+++ --- --- ---
Amastigote 
%(8)*
+ --- 25.0 (2) 12.5 (1)
++ --- --- ---
+++ --- --- ---
Necrosis 
%(8)*
+ 25.0 (2) --- ---
++ --- --- ---
+++ --- --- ---
25(+)
Inflammation 
%(10)*
+ 90.0 (9) 40.0 (4) 10.0 (1)
++ 10.0 (1) 40.0 (4) ---
+++ --- --- ---
Amastigote 
%(10)*
+ 8.3 (1) --- 30.0 (3)
++ --- --- ---
+++ --- --- ---
Necrosis 
%(10)*
+ 20.0 (2) --- ---
++ --- --- ---
+++ --- --- ---
50(+)
Inflammation 
%(8)*
+ 62.5 (5) 25.0 (2) 37.5 (3)
++ 12.5 (1) 12.5 (1) ---
+++ --- --- ---
Amastigote 
% (8)*
+ 12.5 (1) --- ---
++ --- --- ---
+++ --- --- ---
Necrosis 
%(8)*
+ 12.5 (1) --- ---
++ 12.5 (1) --- ---
+++ --- --- ---
75(+)
 
Inflammation 
%(12)*
+ 83.3 (10) 58.3 (7) 24.9 (3)
++ --- --- ---
+++ --- --- ---
Amastigote 
%(12)*
+ 8.3 (1) --- ---
++ --- --- ---
+++ --- --- ---
Necrosis 
%(12)*
 + 16.6 (2) --- ---
 ++ --- --- ---
 +++ --- --- ---
Rev Inst Med Trop São Paulo. 2017;59:e73
Antioxidant effect of Morus nigra on Chagas disease progression
Page 9 of 11
the chronic use of ethanol, which according to Gomes and 
Pereira36 can induce alterations in the nonspecific defense 
mechanisms or in immune responses. Thus, the chronic use 
of alcohol could explain the results disagreements reported 
by Gusmão et al.37 when studying the parasitemia infected 
with the QM2 strain of T. cruzi receiving only water.
Although some studies have shown that the decrease of 
parasites influences the reduction of cardiac damage and 
the increase of animals’ survival, our results showed that 
although the 25(+) group presented lower parasitemia in 
the acute phase, the reduction of the inflammatory process 
in histopathological studies was observed in the 50(+) 
group (Table 3). These differences may be related to the 
levels of active compounds present in the different dosages 
administered, since they may inhibit oxidation processes 
in certain systems, but this does not mean that they can 
protect cells and tissues from all types of oxidative damages, 
since they may present pro-oxidant activity under certain 
conditions38,39.
Our results evidenced complex interactions in the 
defense systems according to the infection status, as well as 
the possible effect of the phytotherapy compound’s vehicle 
itself on the evaluated parameters.
Thus, administration of the phytotherapy compound 
showed a maximal effect on FRAP at the 50 μL dosage 
(Figure 3) that could translate a beneficial protection effect 
for cells and tissues from the oxidative damage, since this 
method mainly reflects the reducing action of these phenolic 
compounds40.
This dosage was still effective in increasing another 
defense mechanism, such as total sulfhydryl groups reaction 
(Figure 6) that represent the first line of defense, and the 
most ready source of antioxidants in plasma that can act in 
situations in which vitamins C and E are not effective, acting 
also as savers of these vitamins41. This parameter relates 
to all thiols found in GSH and plasma proteins, such as 
albumin, and low molecular weight compounds consisting 
of free sulfhydryl, reduced cysteine residues in particular, 
cystenyl glycine and others which are targeted during the 
oxidative attack38,42.
The reduction of sulfhydryl groups concentration could 
reflect the oxidative alteration of proteins resulting in a 
decrease in the arsenal of antioxidant defenses, which could 
be observed in the FRAP result of the infected groups which 
would be used to neutralize the free radicals generated, 
minimizing their damage on cellular structures.
In the present study, it is possible that T. cruzi infection 
has induced a minimized oxidative stress by mobilizing a 
defense arsenal that also combated the damage produced 
by alcohol. Unexpectedly, the presence of infection also 
appears to decrease TBARS levels (Figure 4), as can be 
observed in the C(+) group which had a 50% reduction 
when compared to C(-) (p <0.05).
However, when comparing the uninfected groups with 
their infected counterparts, it was evidenced that the 25μL 
dosage resulted in a statistically significant reduction of 
parasitemia. Considering that this group presented, in 
absence of infection, a high concentration of TBARS, 
this expressive reduction in the presence of infection may 
suggest, once again, that the mobilized antioxidant defenses 
during infection has also acted in this situation.
It was observed that the phytotherapy compound was 
able to increase glutathione concentrations (Figure 5) in 
the absence of infection, which provided a possible defense 
against the oxidative stress caused by infection, as can be 
observed by the reduction of glutathione concentration in 
infected groups.
The possible regulatory role of some flavonoids on the 
level of glutathione γ-SGC (γ-glutamylcysteine synthetase) 
was investigated in incubated cells that received different 
treatments. Flavonoids usually limit the rate of protein 
synthesis and regulate intracellular GSH levels, capable 
of increasing the intracellular concentration of glutathione 
γ-GCS by approximately 50%43. 
The metabolism of glutathione and the interaction with 
the chronic use of ethanol is not well defined and may be 
related to the time of exposure. Studies have reported that 
chronic ethanol administration may increase the activity of 
glutathione peroxidase enzymes by 45% as a consequence 
of their action on peroxidation and glutathione reductase 
activities leading to a 15% reduction as a result of increased 
GSH demand for their oxidized form44,45.
Molina et al.46 reported that ethanol and its metabolites 
facilitate biomolecules’ oxidation, acting directly as 
Figure 7 – Histological preparations of infected animals stained 
with hematoxylin-eosin: A) presence of inflammation in the 
control animal’s colon; B) presence of amastigotes nests in 
the skeletal musculature of animals from the 50 µL group; C) 
myocardial necrosis in a sample from a 25 µL group animal
Montenote et al.
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oxidants reducing antioxidant levels or by combining 
both phenomena, increasing the levels of molecules with 
antioxidant properties such as flavonoids. These molecules 
have been increasingly investigated as possible therapeutic 
agents for the processes of tissue injury resulting from 
the excessive ethanol intake, demonstrating the protective 
effect of these substances against the oxidative stress caused 
by the excess consumption of ethanol. In our study, the 
increase of glutathione observed in the groups treated with 
the phytotherapy compound , has demonstrated a beneficial 
effect in the process of T. cruzi infection, more specifically 
regarding the level of tissue inflammation observed in 
the 50(+) group (Table 3). Apparently, the phytotherapy 
compound could induce a response and this response may 
have been relevant in the context of infection. 
The presence of this response to the phytotherapy 
compound administration may be important, since previous 
research has reported that, in the chronic phase of disease, 
there is a depletion of the antioxidant defense system 
involving glutathione, which no longer responds to up 
regulation mechanisms as occurs in the acute phase47,48. 
Thus, the results of this study corroborate other 
researches, making it evident that natural products may be 
a source of new drugs with high activity and low toxicity 
of their secondary metabolites and that the M. nigra leaves 
are a promising source of natural compounds that should 
be considered for future studies, which could provide 
alternatives for Chagas disease treatment.
However, more detailed studies are needed mainly 
regarding the mechanisms of action and bioavailability, 
as well as the isolation and characterization of the 
phytotherapy compounds detected or not in this work, 
in order to collaborate with possible pharmacological 
applications of this M. nigra phytotherapy compound. 
herbal medicine. 
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